Kai Dallmeier

6.6k total citations
72 papers, 2.2k citations indexed

About

Kai Dallmeier is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Hepatology. According to data from OpenAlex, Kai Dallmeier has authored 72 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 34 papers in Public Health, Environmental and Occupational Health and 15 papers in Hepatology. Recurrent topics in Kai Dallmeier's work include Mosquito-borne diseases and control (33 papers), Viral Infections and Vectors (19 papers) and Viral gastroenteritis research and epidemiology (14 papers). Kai Dallmeier is often cited by papers focused on Mosquito-borne diseases and control (33 papers), Viral Infections and Vectors (19 papers) and Viral gastroenteritis research and epidemiology (14 papers). Kai Dallmeier collaborates with scholars based in Belgium, United States and Germany. Kai Dallmeier's co-authors include Johan Neyts, Yannick Debing, Dirk Jochmans, Xavier de Lamballerie, Suzanne J. F. Kaptein, Pieter Leyssen, Jan Paeshuyse, Boris Pastorino, Joanna Żmurko and Joana Rocha‐Pereira and has published in prestigious journals such as Nature Communications, Nature Genetics and Gastroenterology.

In The Last Decade

Kai Dallmeier

66 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Dallmeier Belgium 23 1.5k 747 538 396 296 72 2.2k
German A. Shipulin Russia 21 761 0.5× 424 0.6× 96 0.2× 313 0.8× 372 1.3× 185 1.7k
Sally A. Baylis Germany 27 1.4k 0.9× 207 0.3× 928 1.7× 484 1.2× 164 0.6× 77 2.4k
Sean M. Amberg United States 17 1.1k 0.7× 584 0.8× 53 0.1× 304 0.8× 214 0.7× 22 1.6k
Pamela J. Glass United States 22 1.3k 0.8× 526 0.7× 39 0.1× 326 0.8× 312 1.1× 47 1.7k
Michiyo Kataoka Japan 21 771 0.5× 90 0.1× 174 0.3× 275 0.7× 256 0.9× 77 1.4k
Ming Qiao Australia 19 423 0.3× 303 0.4× 427 0.8× 554 1.4× 160 0.5× 36 1.1k
Francisco Veas France 26 602 0.4× 599 0.8× 62 0.1× 567 1.4× 356 1.2× 58 2.0k
Zhongyu Hu China 13 588 0.4× 116 0.2× 114 0.2× 303 0.8× 438 1.5× 32 1.3k
Fernando Simón Spain 32 3.0k 2.0× 1.1k 1.5× 38 0.1× 215 0.5× 236 0.8× 153 3.9k
Hiroko Miyamoto Japan 21 930 0.6× 145 0.2× 135 0.3× 683 1.7× 207 0.7× 54 1.4k

Countries citing papers authored by Kai Dallmeier

Since Specialization
Citations

This map shows the geographic impact of Kai Dallmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Dallmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Dallmeier more than expected).

Fields of papers citing papers by Kai Dallmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Dallmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Dallmeier. The network helps show where Kai Dallmeier may publish in the future.

Co-authorship network of co-authors of Kai Dallmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Dallmeier. A scholar is included among the top collaborators of Kai Dallmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Dallmeier. Kai Dallmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dallmeier, Kai, et al.. (2025). Mission 2030: Toward universal hepatitis B immunization. Human Vaccines & Immunotherapeutics. 21(1). 2473222–2473222. 2 indexed citations
2.
Dallmeier, Kai & Yeranddy A. Alpízar. (2025). Rationalizing and mitigating the risk of live-attenuated dengue vaccines. International Journal of Infectious Diseases. 163. 108242–108242.
3.
Sharma, Sapna, et al.. (2024). SeParate: multiway fluorescence-activated droplet sorting based on integration of serial and parallel triaging concepts. Lab on a Chip. 24(7). 2107–2121. 8 indexed citations
4.
Chiu, Winston, Madina Rasulova, Thomas Vercruysse, et al.. (2024). Multiplexed multicolor antiviral assay amenable for high-throughput research. Nature Communications. 15(1). 42–42. 4 indexed citations
5.
Maas, Elke, Ria Lassaunière, Birgit Weynand, et al.. (2024). Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19. Microorganisms. 12(12). 2591–2591.
6.
Lemmens, Viktor, Sarah Debaveye, Winston Chiu, et al.. (2023). YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge. npj Vaccines. 8(1). 99–99. 5 indexed citations
7.
8.
Sharma, Sapna, Thomas Vercruysse, Lorena Sánchez-Felipe, et al.. (2022). Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters. Nature Communications. 13(1). 6644–6644. 12 indexed citations
9.
Boudewijns, Robbert, Patricia Pérez, Dominique Van Looveren, et al.. (2022). MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters. Frontiers in Immunology. 13. 845969–845969. 16 indexed citations
10.
Ma, Ji, Sander Jansen, Bert Malengier‐Devlies, et al.. (2022). Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models. EBioMedicine. 83. 104240–104240. 5 indexed citations
11.
Ma, Ji, Robbert Boudewijns, Lorena Sánchez-Felipe, et al.. (2021). Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice. Emerging Microbes & Infections. 10(1). 2279–2290. 10 indexed citations
12.
Jansen, Sander, Daniëlle Copmans, Sarah Debaveye, et al.. (2021). Identification of host factors binding to dengue and Zika virus subgenomic RNA by efficient yeast three-hybrid screens of the human ORFeome. RNA Biology. 18(5). 732–744. 8 indexed citations
13.
Baggen, Jim, Leentje Persoons, Els Vanstreels, et al.. (2021). Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nature Genetics. 53(4). 435–444. 134 indexed citations
14.
Sharma, Sapna, Michael Schmid, Lorena Sánchez-Felipe, et al.. (2020). Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine. Human Vaccines & Immunotherapeutics. 16(9). 2196–2203. 8 indexed citations
15.
Funnell, Simon G. P., William E. Dowling, César Muñoz‐Fontela, et al.. (2020). Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nature Communications. 11(1). 4253–4253. 37 indexed citations
16.
Mishra, Niraj, Robbert Boudewijns, Michael Schmid, et al.. (2020). A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies. mBio. 11(2). 29 indexed citations
17.
Sun, Liang, Hyunwook Lee, Hendrik Jan Thibaut, et al.. (2019). Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid. PLoS Pathogens. 15(5). e1007760–e1007760. 25 indexed citations
18.
Bardiot, Dorothée, Michael McNaughton, Suzanne J. F. Kaptein, et al.. (2018). Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors. Journal of Medicinal Chemistry. 61(18). 8390–8401. 48 indexed citations
19.
Kum, Dieudonné Buh, Niraj Mishra, Robbert Boudewijns, et al.. (2018). A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice. npj Vaccines. 3(1). 56–56. 34 indexed citations
20.
Theys, Kristof, Pieter Libin, Kai Dallmeier, et al.. (2017). Zika genomics urgently need standardized and curated reference sequences. PLoS Pathogens. 13(9). e1006528–e1006528. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by German A. Shipulin Breakdown of academic impact, for papers by Sally A. Baylis Breakdown of academic impact, for papers by Sean M. Amberg Breakdown of academic impact, for papers by Pamela J. Glass Breakdown of academic impact, for papers by Michiyo Kataoka Breakdown of academic impact, for papers by Ming Qiao Breakdown of academic impact, for papers by Francisco Veas Breakdown of academic impact, for papers by Zhongyu Hu Breakdown of academic impact, for papers by Fernando Simón Breakdown of academic impact, for papers by Hiroko Miyamoto
Rankless by CCL
2026